Page 2 of Mankind Pharma

Mankind Pharma, Mankind Pharma Q2 results, revenue, profit, EBITDA, domestic revenue, export, Cash flow

Mankind Pharma Q2 profit rises by 19.4% to Rs 501.03 crore, revenue at Rs 2708.10 crore

Mankind Pharma posted revenue from operations at Rs 2708.10 crore, 11.6 per cent as against Rs 2425.84 crore during the…

November 1, 2023 10:17 IST

Dhruv Malhotra, poonam juneja, ramesh juneja, mankind, mankind pharma, ramesh juneja mankind condom, condom, mankind pregnancy kit, mankind condom updates, who is poonam juneja, poonam junja net worth, Dhruv Malhotra net worth, Dhruv Malhotra everest group

Meet Dhruv Malhotra, the man who bought Mankind Pharma’s Poonam Juneja’s Delhi property: Know about his journey & net worth

Poonam Juneja is the wife of Ramesh Juneja, the founder of Mankind Pharma.

Updated: May 31, 2023 16:55 IST

Mankind Pharma, fourth quarter, profit, revenue, EBITDA, domestic business, exports, consumer healthcare, Manforce, Prega News

Mankind Pharma posts Q4FY23 profit at Rs 285.44 crore, revenue up 18.9%

Mankind Pharma posted revenue from operations at Rs 2052.67 crore, up 18.9 per cent as against Rs 1725.76 crore in…

May 31, 2023 10:29 IST

Mankind Pharma says no impact of I-T raids on operational performance

Mankind Pharma stated that the Company and its subsidiaries are cooperating with the officials of the Income Tax Department and…

May 11, 2023 16:00 IST

Mankind Pharma share falls 6% today after gaining 32% over IPO price; should you buy, sell or hold?

As Mankind Pharma shares fell 6% in trade today following its bumper listing on the bourses yesterday, analysts are mixed…

May 10, 2023 12:46 IST

Mankind Pharma IPO’s success raises revival hopes for moribund public issue market

Mankind Pharma IPO was massively oversubscribed, at 15.3 times, at close yesterday.

Updated: April 28, 2023 09:07 IST

mankind pharma, IPO, subscription, retail investors, QIBs, public issue, shares

Mankind Pharma IPO Day 3: Issue oversubscribed 15.32 times, QIBs subscribed 4916% for their portion; GMP falls

The portion for retail investors remains undersubscribed as investors bid only 0.92 times of the shares reserved for RIIs. The…

April 27, 2023 17:50 IST

Mankind Pharma IPO Day 2: Issue subscribed 87%; QIBs, NIIs overbid for their portion

Mankind Pharma shares’ GMP fell to Rs 30 on Wednesday, compared to Rs 92 per equity share on Monday. The…

April 26, 2023 17:38 IST

Ramesh Juneja, Mankind Pharma, Mankind Condom, Condom owner, Sex condom, Ramesh Juneja net worth, Ramesh Juneja education, Ramesh Juneja family, Ramesh Juneja condom, lifestyle

Meet Ramesh Juneja, chairman of Mankind Pharma; Know about his Rs 34,500 crore net worth, career & more

Ramesh Juneja is the chairman of Mankind Pharma which he started with his brother Rajeev Juneja.

April 26, 2023 09:15 IST

Mankind Pharma IPO Day 1: Issue subscribed 14%, HNIs subscribed one-third of quota

Qualified institutional buyers (QIBs) subscribed for 8% of their reserved portion. Retail investors bid 14,39,737 times of the shares reserved…

April 25, 2023 18:28 IST

Mankind Pharma’s IPO opens tomorrow — Here’s all you need to know

Mankind Pharma IPO: During the press conference today, Rajeev Juneja, Managing Director of Mankind Pharma, informed that in the past…

April 24, 2023 19:32 IST

Mankind Pharma, Mankind Pharma ipo, Mankind Pharma ipo valuation,

Mankind Pharma eyes $5.26-bn valuation in IPO

Sets Rs 1,026-1,080 price band to raise Rs 4,326 crore via OFS route

April 20, 2023 03:15 IST

Mankind Pharma IPO to open on April 25; all OFS, no fresh issue, 4 crore shares on sale

Mankind Pharma IPO is entirely an offer for sale (OFS) of 40,058,844 equity shares by promoters and other existing shareholders.

Updated: April 18, 2023 13:30 IST

Mankind Pharma eyes Rs 4,700 crore through IPO

“The company is looking to launch the IPO by the end of this month, depending on regulatory approvals. This would…

Updated: April 5, 2023 07:25 IST

Rare Diseases, Ministry of Health, Ministry of Finance, Rare Diseases Treatment, Custom Duty, Healthcare news,

Mankind Pharma reduces price of its heart failure drug by 70 percent in India

Studies show that heart failure claims more than 17.9 million lives every year globally whilst, medicines for critically ill heart…

January 25, 2023 12:39 IST

Venus Remedies, Cisplatin, healthcare news, pharma news,

Mankind Pharma invests in Actimed Therapeutics for clinical developments in cancer

Following the investment, Atish Majumdar, President (Sales & Marketing) of Mankind Pharma joins Actimed Therapeutics as a member of its…

January 23, 2023 16:09 IST

Venus remedies, cancer drugs, cancer treatment, palestine, uzbekistan, healthcare news, pharma news,

Mankind Pharma’s HealthOK revamps its multivitamin tablet

According to the company, the new consumer-engaging and attractive packaging is intended to symbolise invigorated capacity and to reinforce the…

December 29, 2022 16:08 IST

Mankind Pharma, pet industry, Mankind Pharma India, Health news, pharma news, pet food,

Mankind Pharma forays into pet-care segment; Launches dog food

According to the company, India has seen growth in pet ownership in the last decade which increased during the pandemic.

December 21, 2022 12:09 IST

Related News

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar link and KYC rules explained

Big Aadhaar update from November 2025: No document upload needed — UIDAI to verify details automatically

WinTrack highlighted a case of an entrepreneur allegedly harassed by customs at Indira Gandhi International Airport in Delhi, stressing that “genuine entrepreneurs face harassment frequently”.

‘Reccuring problem at Indian airports’: Wintrack highlights case of entrepreneur harassed by customs at Delhi Airport

Techie discusses move back to India amid Green Card concerns.

Techie plans return to India after 15 years in US amid green card uncertainty, says ‘want to move before…’

H-1B visa fee, H-1B filing fees update, US work visa latest news, F-1 student visa new rules, H-1B petition fee waiver, US immigration fee changes, H-1B petition fee removed, H-1B extension fee relief, F-1 to H-1B transition rules,

US announces new immigration rules benefiting H-1B visa holders and F-1 students in America

10 common bank transactions that can put your savings account under Income Tax Department's radar

10 common bank transactions that can put your savings account under Income Tax Dept’s radar

Dude Box Office Collection Day 6: Pradeep Ranganathan= grosses over Rs 80 crore worldwide

Life3 hr ago

Tamil film Dude, directed by Pradeep Ranganathan, is a major success at the box office, earning over Rs 65 crore worldwide in just four days. The film, released during Diwali, has seen a steady rise in collections, with a 2% increase in Tamil regions on Monday. Despite competition from Bollywood release Thamma, Dude continues to draw crowds, with a solid domestic collection of Rs 54 crore.

View all shorts